Results from Cytori Therapeutics' (NASDAQ: CYTX) preclinical fat grafting study have been published in the February issue of the Annals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE